Literature DB >> 34266342

Variable selection for a mark-specific additive hazards model using the adaptive LASSO.

Dongxiao Han1, Lianqiang Qu2, Liuquan Sun3,4, Yanqing Sun5.   

Abstract

In HIV vaccine efficacy trials, mark-specific hazards models have important applications and can be used to evaluate the strain-specific vaccine efficacy. Additive hazards models have been widely used in practice, especially when continuous covariates are present. In this article, we conduct variable selection for a mark-specific additive hazards model. The proposed method is based on an estimating equation with the first derivative of the adaptive LASSO penalty function. The asymptotic properties of the resulting estimators are established. The finite sample behavior of the proposed estimators is evaluated through simulation studies, and an application to a dataset from the first HIV vaccine efficacy trial is provided.

Entities:  

Keywords:  Adaptive LASSO; additive hazards model; competing risks; continuous mark; mark-specific vaccine effects; survival data

Mesh:

Substances:

Year:  2021        PMID: 34266342      PMCID: PMC9140222          DOI: 10.1177/09622802211023957

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   2.494


  12 in total

1.  Tests for comparing mark-specific hazards and cumulative incidence functions.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Lifetime Data Anal       Date:  2004-03       Impact factor: 1.588

2.  The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Biostatistics       Date:  2007-08-17       Impact factor: 5.899

3.  Variable Selection in Nonparametric Varying-Coefficient Models for Analysis of Repeated Measurements.

Authors:  Lifeng Wang; Hongzhe Li; Jianhua Z Huang
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

4.  Shrinkage Estimation of Varying Covariate Effects Based On Quantile Regression.

Authors:  Limin Peng; Jinfeng Xu; Nancy Kutner
Journal:  Stat Comput       Date:  2014-09-01       Impact factor: 2.559

5.  Model selection for Cox models with time-varying coefficients.

Authors:  Jun Yan; Jian Huang
Journal:  Biometrics       Date:  2012-04-16       Impact factor: 2.571

6.  Mark-specific additive hazards regression with continuous marks.

Authors:  Dongxiao Han; Liuquan Sun; Yanqing Sun; Li Qi
Journal:  Lifetime Data Anal       Date:  2016-05-11       Impact factor: 1.588

7.  Model selection and inference for censored lifetime medical expenditures.

Authors:  Brent A Johnson; Qi Long; Yijian Huang; Kari Chansky; Mary Redman
Journal:  Biometrics       Date:  2015-12-21       Impact factor: 2.571

8.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

9.  Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.

Authors:  Yanqing Sun; Mei Li; Peter B Gilbert
Journal:  Biostatistics       Date:  2012-07-03       Impact factor: 5.899

10.  The antigenic structure of the HIV gp120 envelope glycoprotein.

Authors:  R Wyatt; P D Kwong; E Desjardins; R W Sweet; J Robinson; W A Hendrickson; J G Sodroski
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.